Cebiotex Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

Cebiotex General Information

Description

Developer of electrospun nanofiber technology designed to help clients in the local treatment of unresectable cancer tumors. The company's technology has developed in vitro and in vivo and preclinical nonwoven nanofiber membranes for the controlled release of active agents, which are biocompatible and biodegradable membranes without chemical interaction between the nanofiber polymer and the agent applied, enabling medical professionals to treat multiple indications and use for a wide variety of drugs to improve therapeutic options.

Contact Information

Website
www.cebiotex.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Laietana, 26
  • Tech Barcelona Pier 07, Mezzanine
  • 08003 Barcelona
  • Spain
Primary Industry
Drug Discovery
Vertical(s)
Nanotechnology, Life Sciences, Oncology
Corporate Office
  • Via Laietana, 26
  • Tech Barcelona Pier 07, Mezzanine
  • 08003 Barcelona
  • Spain

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cebiotex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Secondary Transaction - Private 01-Mar-2026 Completed Generating Revenue
11. Later Stage VC (Series A) 24-Sep-2021 Completed Generating Revenue
10. Equity Crowdfunding 22-Dec-2020 Completed Generating Revenue
9. Seed Round 10-Feb-2020 Completed Generating Revenue
8. Seed Round 16-Feb-2017 Completed Generating Revenue
7. Grant 12-Dec-2016 Completed Generating Revenue
6. Equity Crowdfunding 31-May-2016 Completed Startup
5. Equity Crowdfunding Completed Startup
4. Seed Round 27-Feb-2015 $567K $2.4M Completed Startup
3. Seed Round 19-Nov-2013 $1.83M $1.83M Completed Startup
To view Cebiotex’s complete valuation and funding history, request access »

Cebiotex Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 2,837 $1.179683 $551.77 $551.77 1x $551.77 21.42%
Ordinary 1,276 $1.179683 $255.66 $255.66 1x $255.66 9.63%
To view Cebiotex’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cebiotex Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Cebiotex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3829549-A1 Beaded nonwoven membrane as a drug delivery system Active 03-Aug-2018
EP-3829549-B1 Beaded nonwoven membrane as a drug delivery system Active 03-Aug-2018
ES-2935179-T3 Beaded nonwoven membrane as a drug delivery system Active 03-Aug-2018
US-12324861-B2 Beaded nonwoven membrane as a drug delivery system Active 03-Aug-2018
US-20210154151-A1 Beaded nonwoven membrane as a drug delivery system Active 03-Aug-2018 A61K9/70
To view Cebiotex’s complete patent history, request access »

Cebiotex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cebiotex Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Namarel Ventures Venture Capital Minority
Inveready Asset Management Venture Capital Minority
Horizon 2020 Government
Caixa Capital Risc Corporate Venture Capital Minority
Universitat Politècnica de Catalunya University
To view Cebiotex’s complete investors history, request access »

Ready to get started?

Request a free trial

Cebiotex FAQs

  • When was Cebiotex founded?

    Cebiotex was founded in 2012.

  • Where is Cebiotex headquartered?

    Cebiotex is headquartered in Barcelona, Spain.

  • What is the size of Cebiotex?

    Cebiotex has 9 total employees.

  • What industry is Cebiotex in?

    Cebiotex’s primary industry is Drug Discovery.

  • Is Cebiotex a private or public company?

    Cebiotex is a Private company.

  • What is Cebiotex’s current revenue?

    The current revenue for Cebiotex is .

  • How much funding has Cebiotex raised over time?

    Cebiotex has raised $11.9M.

  • Who are Cebiotex’s investors?

    Namarel Ventures, Inveready Asset Management, Horizon 2020, Caixa Capital Risc, and Universitat Politècnica de Catalunya have invested in Cebiotex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process